From TGF-β to Cancer Therapy
Journal:
Current Drug Targets
Volume:
4
Page:
243-250
Author(s):
Xuemei Huang and Chung Lee
Therapeutic Targets for Metastatic Prostate Cancer
Journal:
Current Drug Targets
Volume:
4
Page:
251-261
Author(s):
Terry L. Timme, Takefumi Satoh, Salahaldin A. Tahir, Hongyu Wang, Bin S. The, E. Brian Butler, Brian J. Miles, Robert J. Amato, Dov Kadmon and Timothy C. Thompson
Survivin: Role in Normal Cells and in Pathological Conditions
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
131-152
Author(s):
L. O'Driscoll, R. Linehan and M. Clynes
Tumoral Drug Metabolism: Perspectives and Therapeutic Implications
Journal:
Current Drug Metabolism
Volume:
4
Page:
131-149
Author(s):
M. M. Doherty and M. Michael
ACE Inhibitors and AII Receptor Antagonists in the Treatment and Prevention of Bone Marrow Transplant Nephropathy
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
737-749
Author(s):
J. E. Moulder, B. L. Fish and E. P. Cohen
HLA Peptide-mediated Strategies for Modulation of Cellular and Humoral Immune Response in Transplantation
Journal:
Current Pharmacogenomics
Volume:
1
Page:
17-36
Author(s):
A. C. Papassavas
The Leukocyte Common Antigen-Related Protein LAR: Candidate PTP for Inhibitory Targeting
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
809-819
Author(s):
Charles M. LeVea and Robert A. Mooney
Assessment of Gene Transfer Using Imaging Methodology
Journal:
Current Genomics
Volume:
4
Page:
167-184
Author(s):
Annette Altmann and Uwe Haberkorn
Receptor Tyrosine Kinases: The Main Targets for New Anticancer Therapy
Journal:
Current Drug Targets
Volume:
4
Page:
113-121
Author(s):
Joachim Drevs, Michael Medinger, Carmen Schmidt-Gersbach, Renate Weber and Clemens Unger
Current Targets for Anticancer Drug Discovery
Journal:
Current Drug Targets
Volume:
4
Page:
159-179
Author(s):
Nguyen-Hai Nam and Keykavous Parang